In the PNET case, a prevalence (70 %) of CD45 negative, CD56/CD34 positive cells was documented flanked by a population of CD45/CD4dim/CD14 positive monocytes and CD4 reactive T lymphocytes. The gene discussed is CD4; the disease is primitive neuroectodermal tumor.